COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India.

Ray, Arunima; Debata, Ipsita; Agrawal, Ishan; Panda, Maitreyee

Ray, Arunima; Debata, Ipsita; Agrawal, Ishan; Panda, Maitreyee.

Ray A; Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, India.
Debata I; Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, India.
Agrawal I; Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, India.
Panda M; Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, India.

Dermatol Ther ; 33(6): e14036, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-721112

Subject(s)

COVID-19/virology; Dermatologic Agents/administration & dosage; Dermatologists/trends; Immunosuppressive Agents/administration & dosage; Practice Patterns, Physicians'/trends; SARS-CoV-2/pathogenicity; Skin Diseases/drug therapy; Attitude of Health Personnel; COVID-19/diagnosis; COVID-19/immunology; Dermatologic Agents/adverse effects; Health Care Surveys; Health Knowledge, Attitudes, Practice; Host-Pathogen Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents/adverse effects; India; Risk Assessment; Risk Factors; SARS-CoV-2/immunology; Skin Diseases/diagnosis; Skin Diseases/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / Practice Patterns, Physicians' / Dermatologic Agents / Dermatologists / SARS-CoV-2 / COVID-19 / Immunosuppressive Agents Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14036

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google